Determination of the causes of ESRD among patients receiving hemodialysis

 

 

REFERENCES

1. World Health Organization. The World Health Report 2002: Reducing Risks and Promoting Quality Life. Geneva: WHO; 2013.
2. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011 Dec; 80(12):1258-70.
3. Alebiosu CO, Ayodele OE. The global burden of chronic kidney disease and the way forward. Ethn Dis. 2005 Summer; 15(3):418-23.
4. Bamgboye EL. End-stage renal disease in sub-Saharan Africa. Ethn Dis. 2006 Spring; 16(2 Suppl 2):S2-5-9.
5. Eggers PW. Has the incidence of end-stage renal disease in the USA and other countries stabilized? Curr Opin Nephrol Hypertens. 2011 May; 20(3):241-5.
6. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006 Mar 9; 354(10):997-9.
7. Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y, Ogbamariam A, Masjuan M, Gebremichael A. The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 2006 Jan; 20(1):59-65.
8. Abolfotouh MA, Abu-Zeid AH, Aziz MA, et al. Prevalence of hypertension in western Saudi Arabia. East Mediterr Health J. 1996; 2(2):211–218.,
9. Kabahizi J., (2005), Impact of Dialysis Adequacy on Patient Outcomes, Faculty of Health Sciences,University of the Witwatersrand
10. Arogundade FA, Sanusi AA, Hassan MO, Akinsola A. The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: is there a change in trend? Afr Health Sci. 2011 Dec; 11(4):594-601.
11. Soyibo AK, Barton EN. Report from the Caribbean renal registry, 2006. West Indian Med J. 2007 Sep; 56(4):355-63.
12. Ojogwu LI, Ukoli FA. A follow up study of adult nephrotic syndrome in Nigerians: outcome and predictors of endstage renal failure. Afr J Med Med Sci.1993 Jun; 22(2):43-50.
13. Diallo AD, Niamkey E, Beda Yao B. [Chronic renal insufficiency in Côte d'Ivoire: study of 800 hospital cases]. Bull Soc Pathol Exot. 1997; 90(5):346-8.French.
14. Veriava Y, du Toit E, Lawley CG, Milne FJ, Reinach SG. Hypertension as a cause of end-stage renal failure in South Africa. J Hum Hypertens. 1990 Aug; 4(4):379-83.
15. Plange-Rhule J, Phillips R, Acheampong JW, Saggar-Malik AK, Cappuccio FP, Eastwood JB. Hypertension and renal failure in Kumasi, Ghana. J Hum Hypertens. 1999 Jan; 13(1):37-40.
16. Tentori F, Zhang J, Li Y, Karaboyas A, Kerr P, Saran R, Bommer J, Port F, Akiba T, Pisoni R, Robinson B. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2012 Nov; 27(11):4180-8.
17. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh K. Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis. 2010 Jan; 55(1):100-12.
18. Kerr P, Perkovic V, Petrie J, Agar J, Disney A; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Dialysis adequacy (HD) guidelines. Nephrology (Carlton). 2005 Oct; 10 Suppl 4:S61-80.
19. Jules Kabahizi, Impact of Dialysis Adequacy on Patient Outcomes, Johannesburg 2005 Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996 Jul; 28(1):53-61.
20. Collins AJ, Foley RN, Gilbertson DT, Chen SC. United States Renal Data System public health surveillance of chronic kidney disease and end stage renal disease. Kidney Int Suppl (2011). 2015 Jun; 5(1):2-7.